Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by the genetic translocation between chromosomes 9 and 22, which gives rise to the Philadelphia (Ph) chromosome and leads to the generation of the BCR-ABL oncogenic fusion gene (1,2). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.